Gilead Combo for Hep C in Europe

[slagle2]

I just saw on CNBC, the financial news program a scroll that said something like:

"GILD (stock symbol for Gilead) Hep C combo just approved on a compassionate uses basis in Europe"

It didn't say which combo was approved and I can't find any other news about this.  CNBC will post this sort of news which is considered "material information" that can influence the price of the stock of the company involved so it is usually truthful.  

[JimmyMose]

This is the new news 21/02/2014 Sovaldi was approved in January by EU
Gilead's Ledipasvir and Sofosbuvir:- European Medicines Agency advises on compassionate use of new combination therapy for chronic hepatitis C
http://hepatitiscnewdrugs.blogspot.com/2014/02/gileads-ledipasvir-and.html

In this specific case, Sweden requested an opinion from the CHMP on the conditions under which early access through compassionate use could be given to a combination of ledipasvir and sofosbuvir, with or without ribavirin, for adult patients with genotype 1 HCV infection and advanced liver disease, who are at a high risk of their liver being no longer able to function normally (decompensation) or death within 12 months if left untreated.

____________________
Another link
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/02/news_detail_002032.jsp&mid=WC0b01ac058004d5c1

[flyinlynn]

"Gilead's Hep C Drug Sovaldi Approved in EU"

"Gilead Sciences Inc. announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection in adults, in combination with other antiviral agents (ribavirin (RBV) and pegylated interferon alpha (peg-IFN))."

http://www.dddmag.com/news/2014/01/gileads-hep-c-drug-sovaldi-approved-eu

Good Luck
Lynn

[jules2551]

http://www.zacks.com/stock/news/120171/European-Approval-for-Gilead-Drug